Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia

Journal of Neuroscience Research

Volumn 89, Issue 8, 2011, Pages 1218-1227

  Barnes, Michael R ^a   Huxley Jones, Julie ^a   Maycox, Peter R ^a   Lennon, Mark ^a   Thornber, Amy ^a   Kelly, Fiona ^a   Bates, Stewart ^a   Taylor, Adam ^a   Reid, Juliet ^a   Jones, Neil ^a   Schroeder, Jörn ^a   Scorer, Carol A ^a   Davies, Ceri ^a   Hagan, Jim J ^a   Kew, James N C ^a   Angelinetta, Claire ^b   Akbar, Tariq ^b   Hirsch, Steven ^b   Mortimer, Ann M ^b,c   Barnes, Thomas R E ^b   De Belleroche, Jackie ^b   more..

^a GLAXOSMITHKLINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Amyloid; Autophagy; Synaptic plasticity

Indexed keywords

MESSENGER RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; NERVE CELL PLASTICITY; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REPRODUCTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSE; TEMPORAL CORTEX; TRANSCRIPTOMICS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREFRONTAL CORTEX; RNA, MESSENGER; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 79957873236     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22647     Document Type: Article

References (45)

1. Akhondzadeh S, Rezaei F, Larijani B, Nejatisafa AA, Kashani L, Abbasi SH. 2006. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophr Res 84: 405-410.
2. Balu DT, Coyle JT. 2011. Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci Biobehav Rev 35: 848-870.
3. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D, Wu W, Uitdehaag BM, Kappos L, Polman CH, Matthews PM, Hauser SL, Gibson RA, Oksenberg JR, Barnes MR. 2009. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 18: 2078-2090.
4. Barbalat G, Chambon V, Franck N, Koechlin E, Farrer C. 2009. Organization of cognitive control within the lateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry 66: 377-386.
5. Bateup HS, Sabatini BL. 2010. For synapses, it's depression not death. Cell 141: 750-752.
6. Beech RD, Lowthert L, Leffert JJ, Mason PN, Taylor MM, Umlauf S, Lin A, Lee JY, Maloney K, Muralidharan A, Lorberg B, Zhao H, Newton SS, Mane S, Epperson CN, Sinha R, Blumberg H, Bhagwagar Z. 2010. Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord 12: 813-824.
7. Bond BC, Virley DJ, Cairns NJ, Hunter AJ, Moore GB, Moss SJ, Mudge AW, Walsh FS, Jazin E, Preece P. 2002. The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR. Brain Res Mol Brain Res 106: 101-116.
8. Chance SA, Casanova MF, Switala AE, Crow TJ. 2008. Auditory cortex asymmetry, altered minicolumn spacing and absence of ageing effects in schizophrenia. Brain 131: 3178-3192.
9. Cherra SJ, Dagda RK, Chu CT. 2010. Autophagy and neurodegeneration: survival at a cost? Neuropathol Appl Neurobiol (in press).
10. Colantuoni C, Hyde TM, Mitkus S, Joseph A, Sartorius L, Aguirre C, Creswell J, Johnson E, Deep-Soboslay A, Herman MM, Lipska BK, Weinberger DR, Kleinman JE. 2008. Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. Brain Struct Funct 213: 255-271.
11. Dayalu P, Chou KL. 2008. Antipsychotic-induced extrapyramidal symptoms and their management. Expert Opin Pharmacother 9: 1451-1462.
12. Goghari VM, Sponheim SR, MacDonald AWIII. 2010. The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. Neurosci Biobehav Rev 34: 468-486.
13. Gottesman II. 1989. Vital statistics, demography, and schizophrenia: editor's introduction. Schizophr Bull 15: 5-7.
14. Hennah W, Porteous D. 2009. The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes. PLoS One 4: e4906.
15. Holmans P, Green EK, Pahwa JS, Ferreira MA, Purcell SM, Sklar P, Owen MJ, O'Donovan MC, Craddock N. 2009. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 85: 13-24.
16. Honea R, Crow TJ, Passingham D, Mackay CE. 2005. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162: 2233-2245.
17. Hopkins AL. 2008. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4: 682-690.
18. Horesh Y, Katsel P, Haroutunian V, Domany E. 2010. Gene expression signature is shared by patients with Alzheimer's disease and Schizophrenia at the superior temporal gyrus. Eur J Neurol (in press).
19. Hughes ZA, Liu F, Marquis K, Muniz L, Pangalos MN, Ring RH, Whiteside GT, Brandon NJ. 2009. Estrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders. Curr Mol Pharmacol 2: 215-236.
20. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. 2004. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry 161: 109-115.
21. Konarzewska B, Wolczynski S, Szulc A, Galinska B, Poplawska R, Waszkiewicz N. 2009. Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Psychoneuroendocrinology 34: 129-139.
22. Lewis DA, Sweet RA. 2009. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Invest 119: 706-716.
23. Maes OC, Schipper HM, Chong G, Chertkow HM, Wang E. 2010. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease. Neurobiol Aging 31: 34-45.
24. Matsuzaki S, Tohyama M. 2007. Molecular mechanism of schizophrenia with reference to disrupted-in-schizophrenia 1 (DISC1). Neurochem Int 51: 165-172.
25. Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R, Barnes MR, Larminie C, Jones N, Lennon M, Davies C, Hagan JJ, Scorer CA, Angelinetta C, Akbar MT, Hirsch S, Mortimer AM, Barnes TR, de BJ. 2009. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 14: 1083-1094.
26. Mestres J, Gregori-Puigjane E. 2009. Conciliating binding efficiency and polypharmacology. Trends Pharmacol Sci. 30: 470-474.
27. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. 2005. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 158: 20-29.
28. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
29. Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, Nicolson R, Bedwell J, Lenane M, Zijdenbos A, Paus T, Evans A. 1999. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 56: 649-654.
30. Renna M, Jimenez-Sanchez M, Sarkar S, Rubinsztein DC. 2010. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 285: 11061-11067.
31. Sarkar S, Rubinsztein DC. 2008. Small molecule enhancers of autophagy for neurodegenerative diseases. Mol Biosyst 4: 895-901.
32. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC. 2005. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170: 1101-1111.
33. Seshadri S, Kamiya A, Yokota Y, Prikulis I, Kano S, Hayashi-Takagi A, Stanco A, Eom TY, Rao S, Ishizuka K, Wong P, Korth C, Anton ES, Sawa A. 2010. Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc Natl Acad Sci U S A 107: 5622-5627.
34. Shen W, Ganetzky B. 2010. Nibbling away at synaptic development. Autophagy 6: 168-169.
35. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Crowe RR, Oksenberg JR, Mirel DB, Kendler KS, Freedman R, Gejman PV. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
36. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Moller HJ, Hartmann A, Shianna KV, Ge D, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di FM, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Muhleisen TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B, Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nothen MM, Peltonen L, Collier DA, Stefansson K. 2008. Large recurrent microdeletions associated with schizophrenia. Nature 455: 232-236.
37. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Borglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Bottcher Y, Olesen J, Breuer R, Moller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Rethelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA, Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de FR, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jonsson EG, Terenius L, Agartz I, Petursson H, Nothen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, Goldstein DB, Stefansson K, Collier DA. 2009. Common variants conferring risk of schizophrenia. Nature 460: 744-747.
38. Stevens JR. 2002. Schizophrenia: reproductive hormones and the brain. Am J Psychiatry 159: 713-719.
39. Tang B, Chang WL, Lanigan CM, Dean B, Sutcliffe JG, Thomas EA. 2009. Normal human aging and early-stage schizophrenia share common molecular profiles. Aging Cell 8: 339-342.
40. Vawter MP, Atz ME, Rollins BL, Cooper-Casey KM, Shao L, Byerley WF. 2006. Genome scans and gene expression microarrays converge to identify gene regulatory loci relevant in schizophrenia. Hum Genet 119: 558-570.
41. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543.
42. Weng L, Dai H, Zhan Y, He Y, Stepaniants SB, Bassett DE. 2006. Rosetta error model for gene expression analysis. Bioinformatics 22: 1111-1121.
43. Woodruff PW, Wright IC, Bullmore ET, Brammer M, Howard RJ, Williams SC, Shapleske J, Rossell S, David AS, McGuire PK, Murray RM. 1997. Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study. Am J Psychiatry 154: 1676-1682.
44. Yankner BA, Lu T, Loerch P. 2008. The aging brain. Annu Rev Pathol 3: 41-66.
45. Zhang L, Yu J, Pan H, Hu P, Hao Y, Cai W, Zhu H, Yu AD, Xie X, Ma D, Yuan J. 2007. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci U S A 104: 19023-19028.